Fund: ARK
ARK Genomic Revolution ETF (dis) | |
US00214Q3020 | |
31-10-2014 | |
Equity | |
Equity Sectors - Health Care | |
ARK Investment Management LLC | |
ARK Investment Management LLC | |
USD | |
1,000 | |
5% |
1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Výkonnosť fondu | -19.14% | -19.11% | -2.71% | -39.96% | -22.52% | -35.08% | - | - | - | N/A | |
Priemerná výkonnosť (36 meraní) | -2.43% | -13.81% | - | - | - | ||||||
Volatilita od priemernej výkonnosti | 18.58% | 71.82% | - | - | - |
Long | Short | Net | |
---|---|---|---|
Stock | 99.84% | 99.84% | |
Bond | |||
Other | 0.16% | 0.16% | |
Cash |
Aktíva | 16,057 mil. |
Počet akcíí | 40 |
Počet dlhopisov | 0 |
Priebež. popl. | |
z toho Mng. popl. | 0.75 |
Výk. prémia | |
Trans. popl. |
Dividenda | 0.382 |
Dividendový výnos | 1.66% |
Rozhodný dátum | 29-12-2021 |
Frekvencia výplaty | ročne |
Giant | 0.41% |
Large | 4.48% |
Medium | 21.88% |
Small | 19.22% |
Micro | 52.44% |
P/E | 23.29% |
P/BV | 2.79% |
Healthcare | 98.02% |
Technology | 1.82% |
Derivatives | |
Výnos do splatnosti p.a. | |
Modifikovaná durácia |
United States | 90.30% |
Canada | 0.70% |
Latin America | |
United Kingdom | 1.41% |
Eurozone | |
Europe - ex Euro | 7.43% |
Europe - Emerging | |
Africa | |
Middle East | |
Japan | |
Australasia | |
Asia - Developed | |
Asia - Emerging | |
Emerging Market | |
Developed Country | 99.84% |
Not Classified |
Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
---|---|---|---|---|---|
CRISPR Therapeutics AG | Healthcare | 7.43% | Twist Bioscience Corp | Healthcare | 5.99% |
Exact Sciences Corp | Healthcare | 5.6% | Recursion Pharmaceuticals Inc Class A | Healthcare | 5.19% |
Schrodinger Inc Ordinary Shares | Healthcare | 4.36% | Beam Therapeutics Inc | Healthcare | 4.15% |
Ionis Pharmaceuticals Inc | Healthcare | 3.99% | Intellia Therapeutics Inc | Healthcare | 3.9% |
CareDx Inc | Healthcare | 3.82% | Ginkgo Bioworks Holdings Inc | Healthcare | 3.77% |